As the life sciences industry continues to evolve, companies are increasingly turning to value chain analysis (VCA) to drive profitability and enhance competitive advantage. This strategic tool enables life science companies to systematically assess each...
The life cycle of a drug, from its discovery to market approval and eventual discontinuation, varies significantly depending on the therapeutic class of the drug. Different therapeutic classes, such as antibiotics, oncology drugs, cardiovascular agents,...
i3 Consult uses AI in various ways to solve problems for life science clients. AI technologies can help our clients gather insights, analyze data, and make more informed decisions. Here are some we ways we...
Atorvastatin is a statin medication used to lower cholesterol levels in the blood. It was originally developed by Pfizer and is commonly sold under the brand name Lipitor. Here is a brief overview of its...
In the last of our series of posts on our service offering, i3 Consult from day one of business has also been offering cost reduction analysis as one of its core services to our clients...
i3 Consult from day one of business has been offering value chain analysis as one of its core services to our clients in the life sciences and here are highlighted some of the key reasons...
Executive management of life science companies with their product candidates going through exploratory research or undergoing clinical development bear the mantra “how can we get better drugs to the market faster?” Despite the explosion of...
Despite numerous and efficacious therapies and treatments being readily available in the pharmaceutical supply chain, there has been for some time a critical need for new drugs, especially since viral strain outbreaks from the COVID-19...
i3 Consult is proud to announce that it presented its company profile at the Bionabu Growth Labs event hosted last month Tuesday 25th January. The event has been reviewed as a great success and in...
i3 Consult is releasing a new series of Clinical Trial Reports of unique market intelligence content called Growth Market Share Matrixing. Under this new added value format, investors, pharma product managers, healthcare providers, pharmacists and...